UCB Investor
You see, UCB wants to be a world leader when it comes to treating ailments related to the immune and central nervous systems (CNS).
Technology:
AgeTech Companies
Industry:
AI
Headquarters:
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Founded Date:
1928-01-01
Employees Number:
10001+
Funding Status:
Public
Investment Stage:
Early Stage Venture
Number Of Exits:
3
Acquisitions Number:
Made Acquisitions
Investors Number:
8
Total Funding:
202213820
Estimated Revenue:
$1B to $10B
Last Funding Date:
2022-05-24
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership